Id |
Subject |
Object |
Predicate |
Lexical cue |
T196 |
0-179 |
Sentence |
denotes |
Regarding the absorption parameters, all 20 compounds (Table 2 ) presented a promising oral availability including the optimal Caco-2 cell permeability, HIA and skin permeability. |
T197 |
180-411 |
Sentence |
denotes |
The drug distribution results showed that most of the compounds distributed in tissue (VDss> 0.45: tissue, VDss <−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target. |
T198 |
412-534 |
Sentence |
denotes |
Only compound W5 and W11 were entirely unable to penetrate the blood-brain barrier (BBB) and central nervous system (CNS). |
T199 |
535-669 |
Sentence |
denotes |
In addition, 15 compounds presented a good renal elimination and were not substrates of the renal organic cation transporter 2 (OCT2). |
T200 |
670-925 |
Sentence |
denotes |
Finally, 14 compounds did not present any particular toxicity problems including AMES toxicity, maximum tolerated dose, hERG I inhibitor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity (Fig. 7B). |
T201 |
926-974 |
Sentence |
denotes |
Table 2 20 potential active compounds from QFPD. |
T202 |
975-1040 |
Sentence |
denotes |
Pubchem Molecular Name Structure Pubchem Molecular Name Structure |
T203 |
1041-1101 |
Sentence |
denotes |
CID6918970 M3 ZINC5356864 CID10019512 S5 3-O-Methylviolanone |
T204 |
1102-1147 |
Sentence |
denotes |
CID336327 M5 Medicarpin CID9064 W5 Cianidanol |
T205 |
1148-1194 |
Sentence |
denotes |
CID14057197 O1 – CID182232 W11 (+)-Epicatechin |
T206 |
1195-1251 |
Sentence |
denotes |
CID42607889 O2 Alysifolinone CID25721350 X1 ZINC13130930 |
T207 |
1252-1309 |
Sentence |
denotes |
CID3902 S1 letrozole CID14135323 X2 (2S)-dihydrobaicalein |
T208 |
1310-1359 |
Sentence |
denotes |
CID821279 X4 ZINC338038 CID439246 MXO1 naringenin |
T209 |
1360-1419 |
Sentence |
denotes |
CID440833 MS1 Leucocyanidol CID676152 SO1 SR-01,000,767,148 |
T210 |
1420-1482 |
Sentence |
denotes |
CID177149 MX16 (+)-Vestitol CID11438306 SX1 cyclo(L-Tyr-l-Phe) |
T211 |
1483-1540 |
Sentence |
denotes |
CID114829 MX17 Liquiritigenin CID712316 WO1 (-)-taxifolin |
T212 |
1541-1603 |
Sentence |
denotes |
CID928837 MX8 ZINC519174 CID373261 XO1 Eriodyctiol (flavanone) |
T213 |
1604-1632 |
Sentence |
denotes |
M: MXSG, S: SGMH, X: XCH, O: |
T214 |
1633-1640 |
Sentence |
denotes |
Others. |